Targeting critical steps of cancer metastasis and recurrence using telomerase template antagonists

Z. Gunnur Dikmen, Taner Ozgurtas, Sergei M. Gryaznov, Brittney-Shea Herbert

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Metastasis, tumor relapse, and drug resistance remain major obstacles in the treatment of cancer. Therefore, more research on the mechanisms of these processes in disease is warranted for improved treatment options. Recent evidence suggests that the capability to sustain tumor growth and metastasis resides in a subpopulation of cells, termed cancer stem cells or tumor-initiating cells. Continuous proliferation and self-renewal are characteristics of stem/progenitor cells. Telomerase and the maintenance of telomeres are key players in the ability of stem and cancer cells to bypass senescence and be immortal. Therefore, telomerase inhibitors have the therapeutic potential for reducing tumor relapse by targeting cancer stem cells and other processes involved in metastasis. Herein we review the role of telomerase in the immortal phenotype of cancer and cancer stem cells, targeting telomerase in cancer, and discuss other opportunities for telomerase inhibitors to target critical steps in cancer metastasis and recurrence.

Original languageEnglish
Pages (from-to)240-247
Number of pages8
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1792
Issue number4
DOIs
StatePublished - Apr 2009

Fingerprint

Telomerase
Neoplastic Stem Cells
Neoplasm Metastasis
Recurrence
Neoplasms
Stem Cells
Telomere
Drug Resistance
Maintenance
Phenotype
Growth
Research

Keywords

  • Angiogenesis
  • Cancer stem cell
  • Metastasis
  • Targeted cancer therapy
  • Telomerase
  • Thio-phosphoramidate oligonucleotide

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine

Cite this

Targeting critical steps of cancer metastasis and recurrence using telomerase template antagonists. / Dikmen, Z. Gunnur; Ozgurtas, Taner; Gryaznov, Sergei M.; Herbert, Brittney-Shea.

In: Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1792, No. 4, 04.2009, p. 240-247.

Research output: Contribution to journalArticle

@article{228482ff38ce41f69aba583a05c7770c,
title = "Targeting critical steps of cancer metastasis and recurrence using telomerase template antagonists",
abstract = "Metastasis, tumor relapse, and drug resistance remain major obstacles in the treatment of cancer. Therefore, more research on the mechanisms of these processes in disease is warranted for improved treatment options. Recent evidence suggests that the capability to sustain tumor growth and metastasis resides in a subpopulation of cells, termed cancer stem cells or tumor-initiating cells. Continuous proliferation and self-renewal are characteristics of stem/progenitor cells. Telomerase and the maintenance of telomeres are key players in the ability of stem and cancer cells to bypass senescence and be immortal. Therefore, telomerase inhibitors have the therapeutic potential for reducing tumor relapse by targeting cancer stem cells and other processes involved in metastasis. Herein we review the role of telomerase in the immortal phenotype of cancer and cancer stem cells, targeting telomerase in cancer, and discuss other opportunities for telomerase inhibitors to target critical steps in cancer metastasis and recurrence.",
keywords = "Angiogenesis, Cancer stem cell, Metastasis, Targeted cancer therapy, Telomerase, Thio-phosphoramidate oligonucleotide",
author = "Dikmen, {Z. Gunnur} and Taner Ozgurtas and Gryaznov, {Sergei M.} and Brittney-Shea Herbert",
year = "2009",
month = "4",
doi = "10.1016/j.bbadis.2009.01.018",
language = "English",
volume = "1792",
pages = "240--247",
journal = "Biochimica et Biophysica Acta - Molecular Basis of Disease",
issn = "0925-4439",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Targeting critical steps of cancer metastasis and recurrence using telomerase template antagonists

AU - Dikmen, Z. Gunnur

AU - Ozgurtas, Taner

AU - Gryaznov, Sergei M.

AU - Herbert, Brittney-Shea

PY - 2009/4

Y1 - 2009/4

N2 - Metastasis, tumor relapse, and drug resistance remain major obstacles in the treatment of cancer. Therefore, more research on the mechanisms of these processes in disease is warranted for improved treatment options. Recent evidence suggests that the capability to sustain tumor growth and metastasis resides in a subpopulation of cells, termed cancer stem cells or tumor-initiating cells. Continuous proliferation and self-renewal are characteristics of stem/progenitor cells. Telomerase and the maintenance of telomeres are key players in the ability of stem and cancer cells to bypass senescence and be immortal. Therefore, telomerase inhibitors have the therapeutic potential for reducing tumor relapse by targeting cancer stem cells and other processes involved in metastasis. Herein we review the role of telomerase in the immortal phenotype of cancer and cancer stem cells, targeting telomerase in cancer, and discuss other opportunities for telomerase inhibitors to target critical steps in cancer metastasis and recurrence.

AB - Metastasis, tumor relapse, and drug resistance remain major obstacles in the treatment of cancer. Therefore, more research on the mechanisms of these processes in disease is warranted for improved treatment options. Recent evidence suggests that the capability to sustain tumor growth and metastasis resides in a subpopulation of cells, termed cancer stem cells or tumor-initiating cells. Continuous proliferation and self-renewal are characteristics of stem/progenitor cells. Telomerase and the maintenance of telomeres are key players in the ability of stem and cancer cells to bypass senescence and be immortal. Therefore, telomerase inhibitors have the therapeutic potential for reducing tumor relapse by targeting cancer stem cells and other processes involved in metastasis. Herein we review the role of telomerase in the immortal phenotype of cancer and cancer stem cells, targeting telomerase in cancer, and discuss other opportunities for telomerase inhibitors to target critical steps in cancer metastasis and recurrence.

KW - Angiogenesis

KW - Cancer stem cell

KW - Metastasis

KW - Targeted cancer therapy

KW - Telomerase

KW - Thio-phosphoramidate oligonucleotide

UR - http://www.scopus.com/inward/record.url?scp=64249123166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64249123166&partnerID=8YFLogxK

U2 - 10.1016/j.bbadis.2009.01.018

DO - 10.1016/j.bbadis.2009.01.018

M3 - Article

VL - 1792

SP - 240

EP - 247

JO - Biochimica et Biophysica Acta - Molecular Basis of Disease

JF - Biochimica et Biophysica Acta - Molecular Basis of Disease

SN - 0925-4439

IS - 4

ER -